OOIR: Observatory of International Research

Papers

(The TQCC of Thrombosis Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation	61
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9146 genotype: a case report	56
Association between inflammatory indices and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study	40
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis	30
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis	29
Dietary zinc intake and 10-year atherosclerotic cardiovascular disease risk in diabetes mellitus patients: evidence from NHANES database	26
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms	22
Outcomes and risk factors for functional prognosis at 3 months after intravenous thrombolysis with r-tPA in patients with acute ischemic stroke: a retrospective cohort study	22
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	20
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	20
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	20
Investigating the dual causative pathways linking immune cells and venous thromboembolism via Mendelian randomization analysis	19
Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism	18
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	18
The mechanisms of efficacy and safety of Ginkgo biloba extract in acute ischemic stroke: a real-world study	18
Clinical significance of D-dimer levels during acute period in ischemic stroke	17
Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow	16
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	16
Recurrent, life-threatening PE in the setting of popliteal vein aneurysm in pregnancy: a case report	15
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	15
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	15
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	14
Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients	14
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑19	13
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	13

Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study)	13
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	12
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study	12
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	12
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	11
Hyperlipidemia in immune thrombocytopenia: a retrospective study	11
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)	11
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	11
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study	11
Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study	11
Circular RNA ciRs-126 promotes hypoxia/reoxygenation cardiac injury possibly through miR-21	11
A novel role for protein disulfide isomerase ERp18 in venous thrombosis	11
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements	11
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	11
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice	10
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow	10
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	10
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19	10
An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention	10
Damage-associated molecular patterns and fibrinolysis perturbation are associated with lethal outcomes in traumatic injury	10
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines	9
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review	9
Cancer incidence and mortality after a first-ever venous thrombosis: a cohort study in northern Sweden	9
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications	9
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study	9
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China	9
Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review	9
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis	9
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature	9
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	8
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	8
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19	8
Early coagulopathy after pediatric out-of-hospital cardiac arrest: secondary analysis of a randomized clinical trial	8
Colonization of Fusobacterium nucleatum is an independent predictor of poor prognosis in gastric cancer patients with venous thromboembolism: a retrospective cohort study	8
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	8
The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion	8
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	8
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome	8
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	8
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications	8
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials	7
Evaluation of the efficacy and safety of rivaroxaban compared to warfarin in patients with left ventricular apical thrombus: a randomized clinical trial	7
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study	7
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy	7
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors	7
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review	7
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	7
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study	7
Lipoprotein apheresis: an established therapeutic modality for homozygous familial hypercholesterolemia patients refractory to PCSK9 inhibitors: a case report and literature review	7
Prevalence, predictors and management of left atrial appendage thrombogenic milieu in atrial fibrillation with low thromboembolic risk	6

Venous thromboembolic disease in admitted blunt trauma patients: what matters?	6
Predictors of pulmonary embolism in hospitalized patients with COVID-19	6
Prevalence and risk factor of post-operative lower extremities deep vein thrombosis in patients undergoing gynecologic surgery: a single-institute cross-sectional study	6
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases	6
Risk of heparinoid use in cosmetics and moisturizers in individuals vaccinated against severe acute respiratory syndrome coronavirus 2	6
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	6
Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study	6
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report	6
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	6
Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability	6
How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores	6
Heterozygosity for the Budapest 3 mutation in SERPINC1 in a family with thrombophilia and structural anomalies of the inferior vena cava	6
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	6
The Buerger’s rabbit model: a closer step to unravelling thromboangiitis obliterans?	6
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study	6
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	5
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1	5
Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report	5
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance	5
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report	5
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudina	5
Artificial intelligence in thrombosis: transformative potential and emerging challenges	5
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients	5
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country	5
Correction to: agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage	5
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis	5
Causal effect of gut microbiota on venous thromboembolism: a two-sample mendelian randomization study	5
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	5
Molecular patterns of alpha-thalassemia in the kingdom of Saudi Arabia: identification of prevalent genotypes and regions with high incidence	5
The association of serum total bile acids and deep venous thrombosis	5
Unprovoked venous thromboembolism recurrence and arterial embolism revealing lung cancer: a case report	5
Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation	5
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	5
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia	5
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	5
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis	5
The effect of neutrophil extracellular traps in venous thrombosis	5
Cardiac thrombus in acute ischemic stroke: impact on endovascular thrombectomy utilization	5
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	5
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	5
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients	5
Frontline use of rituximab may prevent ADAMTS13 inhibitor boosting during caplacizumab treatment in patients with iTTP: post hoc analysis of a phase 2/3 study in Japan	5